Breaking News

Genetic study of epilepsy points to potential new therapies

This study will encourage researchers to develop personalised and precision therapies for patients with difficult and ...

Cancer Research UK and AstraZeneca launch functional genomics centre

The centre will be a dedicated resource for AstraZeneca and Cancer Research UK’s academics and alliance partners ...

Follicum teams up with University of Bradford on peptide research

Follicum signs agreement with Centre for Skin Sciences at University of Bradford for mode of action studies

Only a handful of pharma companies are developing the urgently needed new medicines for the poor

The development of new medical products that are considered the highest priority for people in developing countries is ...

Avacta and LG Chem Life Sciences agree multitarget Affimer therapeutics development alliance

Avacta Group, the developer of Affimer biotherapeutics and reagents, and LG Chem Life Sciences, the life sciences ...

Discover, learn and connect at Lab Innovations!

Experience the latest developments at the UK’s only event dedicated to the laboratory industry

BMS and Vedanta announce a new clinical collaboration to evaluate OPDIVO (nivolumab) and VE800

Bristol-Myers Squibb and Vedanta announce a clinical trial collaboration to evaluate BMS' programmed death-1 (PD-1) ...

Nemera organises an expert review on the present and future of inhalation products

Respiratory diseases still impact the everyday life of many people

Plant-based expression systems expedite time to market

Leaf Expression Systems is a new contract development business specialising in the plant-based expression and ...

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge ...

In vivo models to target respiratory diseases

Envigo’s Steve Jordan offers intuitive analysis and insights into methods of optimising in vivo efficacy studies and ...

Axol Bioscience launches human iPSC-derived microglia

A reproducible, physiologically relevant cellular model of human microglia for neurodegenerative disease drug discovery ...

Arcinova awarded £1 million government grant to revolutionise digital medicines manufacturing

Arcinova, a multi-service CRDO, has been awarded a £1 million government grant for its £2 million Fill-Inova project